你即將離開本站

並前往https://www.icmr.gov.in/pdf/press_realease_files/Press_Release_ICMR_03_March_2021.pdf

ICMR Press Release

Phase 3 Clinical Trial of COVAXIN, developed by ICMR & Bharat Biotech, shows 81% efficacy. The results, evaluated by an independent data ...

確定！ 回上一頁

查詢 「Clinical trial gov」的人也找了：